MYLAN-SUMATRIPTAN
MYLAN PHARMACEUTICALS ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MYLAN-SUMATRIPTAN in Canada?
Yes. MYLAN-SUMATRIPTAN 100MG has an active shortage reported to Health Canada (last updated September 2, 2026).
Why is MYLAN-SUMATRIPTAN not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MYLAN-SUMATRIPTAN be available again?
The manufacturer's estimated resolution date is February 9, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
IMITREX TAB 100MG
GLAXO CANADA INC
IMITREX DF - TAB 100MG
GLAXOSMITHKLINE INC
TEVA-SUMATRIPTAN
TEVA CANADA LIMITED
RATIO-SUMATRIPTAN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
RIVA-SUMATRIPTAN
LABORATOIRE RIVA INC.
Q-SUMATRIPTAN
QD PHARMACEUTICALS ULC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02268922
Strength
100MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Shortage of an inactive ingredient or component.
Shortage of an active ingredient.
Delay in shipping of the drug.
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
40MG · DIN 02257963
10MG · DIN 02257955
DIN 02388138
DIN 02388146
50MG · DIN 02468549
2G · DIN 02407310
1G · DIN 02407302
12.5MG · DIN 02554631
100MG · DIN 02247244
25MG · DIN 02247243